Klemens Schütte

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

Dan Ziegler, M Hanefeld, K. J. Ruhnau et al. · Diabetes Care · 1999 · 431 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy

Dan Ziegler, Phillip A. Low, William J. Litchy et al. · Diabetes Care · 2011 · 389 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy

K. Ruhnau, J. ‐R. Finn, M. Reljanović et al. · Diabetic Medicine · 1999 · 177 citations

Medicine, Neurology, Pharmacology +17

Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain

Thomas Först, Terry Smith, Klemens Schütte et al. · British Journal of Clinical Pharmacology · 2007 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17